Please login to the form below
Daily Brief: Andrew Witty's replacement on Accelerated Access initiative, Blincyto gains full EU approval and more
The latest news from across pharma, biotech and healthcare
Irish survey lists pharma firms’ top five Brexit concerns
Talent access restrictions topped the list
Sanofi poaches Peugeot's finance head
Jean-Baptiste Chasseloup de Chatillon joins the French drugmaker as chief financial officer
Sarepta soars on positive Duchenne data
Trial results position Sarepta as a “leader in the field” according to analysts
NHS could save £7bn with greater diagnostics use
Report suggests IVD tests could be key to big savings
Pharma demands guarantees for UK sector deal
Ten companies warn of Brexit threat, and long-standing flaws in medicines access
Freeline raises £88m to accelerate haemophilia gene therapy
Spin-out from London university joins fast-developing field
Roche agrees $2.4bn takeover of genomics player Foundation
Offers a 29% premium on the Foundation’s recent share price
Chiesi targets patient adherence via mobile app
Initiative will see asthma and COPD patients receive device training support
The shifting healthcare landscape
-
The power of pharma businesses to drive social changeThe importance of CSR programmes
-
The new basics Innovative products and creative marketing won’t help if our industry fails to address the new basics
-
Daily Brief, CAR-T update, new leukaemia treatments, universal flu hope and moreHighlights from the world of pharma, biotech and healthcare
-
May earmarks £20bn for the NHS - but experts say it's not enoughBut claims of a “Brexit dividend” are rubbished
-
New trial results suggest CAR-T effects are durable in lymphomaNovartis and Celgene/Juno release longer term data on important lymphoma indication at EHA
-
Evotec says Sanofi deal makes it anti-infectives powerhouseAims to inject biotech nimbleness into anti-infectives portfolio
-
NICE set to reject Kyowa Kirin’s Crysvita for XLHCommittee says the rare disease therapy isn’t value for money
-
More impressive data from Bluebird’s gene therapy in thalassemia and sickle cell diseaseCell and gene therapy specialist Bluebird going head-to-head with partner Celgene
-
UK firm Nightstar bags FDA fast-track status for gene therapyIts choroideremia disease candidate gets RMAT designation
Latest appointments
-
Weekly industry appointmentsGSK’s CSO cell and gene therapy heads for the exit, Gelesis adds to company, Abcam appoints Peter Allen and Joseph Swedish joins Mesoblast’s board
-
Medicen Paris Region appoints new CEOStéphana Roques joins the European health cluster
-
Weekly comms appointments Publicis Resolute, Road and W2O all add to their teams
-
Health Unlimited bolsters PR teamAppoints Ann Bartling as PR practice lead
-
Biogen appoints executive VP, corporate developmentDaniel Karp will also become a member of the executive committee
Featured jobs
- Senior Account Director or Business Unit Director, Healthcare Ad...
-
C£60, 000 – £70, 000 benefits
- Account Director, Training & Medical Communications, London
-
Competitive Salary
-
Scientific Engagement Director
-
Salary will be dependant on experience
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Science Writer – Healthcare Advertising
-
Salary TBC
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
- Multi-Channel Account Managers - Road / Homebased – Full or Part...
-
Competitive salary
- Medical Writer - Medical Communications
-
£30, 000 - £40, 000 according to skills and experience plus benefits
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- Medical Writer, Healthcare Advertising
-
£35 - £45, 000 benefits
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Senior Strategic Planner, Healthcare Brand Communications, Londo...
-
Competitive Salary
Subscribe to our email news alerts
- Roche starts new late-stage trials of Alzheimer’s candidate
- More impressive data from Bluebird’s gene therapy in thalassemia and sickle cell disease
- Moving annual total (MAT)
- New trial results suggest CAR-T effects are durable in lymphoma
- AbbVie builds case for arthritis blockbuster-in-waiting upadacitinib
- Commentary: Roseanne’s racist tweet and Sanofi’s swift and surprising riposte
- Developing advocacy in the pharmaceutical industry
- Weekly industry appointments
- Daily Brief: Andrew Witty's replacement on Accelerated Access initiative, Blincyto gains full EU approval and more
- Improving Outcomes - Patient Engagement & Activation
- Irish survey lists pharma firms’ top five Brexit concerns
- Sanofi poaches Peugeot's finance head
PMHub
Cello Health Insight
Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...
Latest intelligence
- It’s all about patient outcomes… right?
- Lessons from history: a design thinking perspective...
- 30 Women Leaders in UK Healthcare (part 3)
- Continuing our special feature on Women Leaders in UK Healthcare...
- 30 Women Leaders in UK Healthcare
- The enormous challenges facing UK healthcare mean it needs great leaders. PME’s Group Editor Andrew McConaghie introduces 30 outstanding innovators and trailblazers helping to shape the future...
Quick links
Infographics
